This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blessing, E.
Right arrow Articles by Kuo, C.-c.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blessing, E.
Right arrow Articles by Kuo, C.-c.

 Previous Article  |  Next Article 

Infection and Immunity, December 2000, p. 7195-7197, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Effect of Chlamydia trachomatis Infection on Atherosclerosis in Apolipoprotein E-Deficient Mice

Erwin Blessing,1 Sanae Nagano,1,dagger Lee Ann Campbell,1 Michael E. Rosenfeld,1,2 and Cho-chou Kuo1,*

Department of Pathobiology1 and Interdisciplinary Graduate Program in Nutritional Sciences,2 University of Washington, Seattle, Washington 98195

Received 30 June 2000/Returned for modification 8 September 2000/Accepted 21 September 2000

We have previously demonstrated that Chlamydia pneumoniae accelerates plaque formation in apolipoprotein E-deficient (ApoE-/-) mice following intranasal inoculations. In this study, we evaluated the effect of respiratory tract infection with Chlamydia trachomatis on the progression of atherosclerosis in ApoE-/- mice. The study showed that in contrast to infection with Chlamydia pneumoniae, infection of the lung and aorta with C. trachomatis was mild and transient and did not significantly accelerate plaque development.


* Corresponding author. Mailing address: Department of Pathobiology, Box 357238, University of Washington, Seattle, WA 98195. Phone: (206) 543-8689. Fax: (206) 543-3873. E-mail: cckuo{at}u.washington.edu.

dagger Present address: Department of Obstetrics and Gynecology, Okayama University, Okayama 700-8558, Japan.


Infection and Immunity, December 2000, p. 7195-7197, Vol. 68, No. 12
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Naiki, Y., Sorrentino, R., Wong, M. H., Michelsen, K. S., Shimada, K., Chen, S., Yilmaz, A., Slepenkin, A., Schroder, N. W. J., Crother, T. R., Bulut, Y., Doherty, T. M., Bradley, M., Shaposhnik, Z., Peterson, E. M., Tontonoz, P., Shah, P. K., Arditi, M. (2008). TLR/MyD88 and Liver X Receptor {alpha} Signaling Pathways Reciprocally Control Chlamydia pneumoniae-Induced Acceleration of Atherosclerosis. J. Immunol. 181: 7176-7185 [Abstract] [Full Text]  
  • Tormakangas, L., Erkkila, L., Korhonen, T., Tiirola, T., Bloigu, A., Saikku, P., Leinonen, M. (2005). Effects of Repeated Chlamydia pneumoniae Inoculations on Aortic Lipid Accumulation and Inflammatory Response in C57BL/6J Mice. Infect. Immun. 73: 6458-6466 [Abstract] [Full Text]  
  • de Kruif, M. D., van Gorp, E. C.M., Keller, T. T., Ossewaarde, J. M., ten Cate, H. (2005). Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research. Cardiovasc Res 65: 317-327 [Abstract] [Full Text]  
  • Burian, K., Berencsi, K., Endresz, V., Gyulai, Z., Valyi-Nagy, T., Valyi-Nagy, I., Bakay, M., Geng, Y., Virok, D., Kari, L., Hajnal-Papp, R., Trinchieri, G., Gonczol, E. (2001). Chlamydia pneumoniae Exacerbates Aortic Inflammatory Foci Caused by Murine Cytomegalovirus Infection in Normocholesterolemic Mice. CVI 8: 1263-1266 [Abstract] [Full Text]